Cadherin-19 rabbit pAb
ENT-A2297
Description
| REF | ENT-A2297 |
|---|---|
| Category | Antibody Polyclonal |
| Description | Cadherin-19 rabbit pAb |
| Source | Rabbit |
| Applications | WB;IHC;IF;ELISA |
| Reactivity | Human;Rat;Mouse; |
| Reactivity | Human;Rat;Mouse; |
| Dilution | Western Blot: 1/500 – 1/2000. Immunohistochemistry: 1/100 – 1/300. Immunofluorescence: 1/200 – 1/1000. ELISA: 1/20000. Not yet tested in other applications. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human CDH19. AA range:371-420 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 87kD |
| Human Gene ID | 28513 |
| Human Swiss Prot Nº | Q9H159 |
| Subcellular Location | Cell membrane; Single-pass type I membrane protein. |
Other Name: CDH19; CDH7L2; Cadherin-19
Background: This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012],